Highlights bioMérieux

Equities

BIM

FR0013280286

Medical Equipment, Supplies & Distribution

Real-time Euronext Paris Other stock markets 12:26:56 14/01/2026 GMT			5-day change	1st Jan Change
107.80 ^EUR	-0.19%		-5.02%	-2.27%

01-07	BioMérieux Slips Despite Intensifying Flu Season Across the Atlantic
12-04	Biomerieux Launches Leading Endocrinology Testing Offer Dedicated to Enhancing Equine Health	CI

Highlights

12-04	Biomerieux Launches Leading Endocrinology Testing Offer Dedicated to Enhancing Equine Health	CI
11-05	Oxford Nanopore and bioMérieux launch AmPORE-TB, a Research Use Only sequencing-based solution to rapidly characterize drug resistant-tuberculosis	CI
11-04	Biomérieux Q3 earnings miss prompts softer 2025 guidance
11-04	BioMérieux S.A. Provides Earnings Guidance for the Full Year 2025	CI
11-04	Biomerieux cuts 2025 sales growth outlook to max. 6.5%	RE
09/09/25	Altesa BioSciences, Inc. and bioMérieux Announces Collaboration for Altesa's Upcoming Phase 2B COPD Clinical Trial	CI
04/09/25	BioMérieux S.A. Reports Earnings Results for the Half Year Ended June 30, 2025	CI
04/09/25	BioMérieux: Analysts React to Forecast Revision
04/09/25	BIOMÉRIEUX : Oddo BHF confirms rating after new forecasts
04/09/25	Biomérieux S.A. Provides Earnings Guidance for Full Year 2025	CI
04/09/25	BioMérieux Adjusts 2025 Sales Forecast Range Amid Chinese Market Slowdown	RE
04/09/25	Biomerieux H1 net sales at EUR 2.04 bln	RE
26/08/25	OhioHealth Partners with BioMerieux as Newest Global Antimicrobial Stewardship Center of Excellence	CI
19/08/25	BioMérieux Wins US FDA Nod for Anterior Nasal Swab Use in Respiratory PCR Test	MT
18/08/25	BioMerieux Receives U.S. Food and Drug Administration 510(K) Clearance and Clinical Laboratory Improvement Amendments	CI
18/08/25	Biomerieux gets U.S. FDA clearance for additional swab to Biofire Spotfire	RE
05/08/25	BioMerieux Announces the Launch of GENE-Up PRO HRM	CI
16/06/25	BioMérieux S.A. acquired Key Assets of Day Zero Diagnostics Inc.	CI
16/06/25	BioMérieux: agreement to acquire Day Zero Diagnostic
16/06/25	Biomerieux Acquires Day Zero Diagnostics Solutions And Technologies	RE
08/06/25	Ex-dividend day for final dividend	FA
03/06/25	BioMérieux S.A. Launches Equine Infectious Respiratory Disease Testing with VETFIRE	CI
22/05/25	GXO Logistics, Inc. Extends Long-Term Contract Renewal and Extension with BioMerieux	CI
07/05/25	BIOMÉRIEUX : RBC downgrades stock
22/04/25	BIOMÉRIEUX : Invest Securities remains positive, cuts TP

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages MarketScreener Editorial Features MarketScreener Strategies Trading Ideas

Filters

Headlines

Biomérieux Q3 earnings miss prompts softer 2025 guidance

November 04, 2025 at 07:51 pm